Morocco Fines Viatris $760,000 for Failing to Report Merger
The American pharmaceutical giant Viatris Inc. is being fined 7.58 million dirhams (about $760,000) by the Moroccan competition authority. The reason: the group did not notify its creation resulting from the merger between Mylan and Upjohn (Pfizer) in 2020, as required by the regulations.
The fine, which represents 2.5% of Viatris’ turnover in Morocco in 2022, has been paid to the Moroccan treasury. The company has chosen not to contest the decision and will not appeal, Reuters reports.
To read: Moroccan Call Center Fined €50,000 for Solar Panel Scam Targeting French Residents
This conviction is part of the Moroccan authorities’ desire to strengthen the control of concentration operations. The regulator announces its intention to examine other mergers that have not been notified, including the joint venture between OCP and Fertinagro Biotech, as well as Whirlpool’s acquisition of activities by the Turkish Arçelik, the same source specifies.
Related Articles
-
Morocco’s $38 Billion Infrastructure Overhaul: Paving the Way for Regional Dominance
7 September 2025
-
Morocco Cracks Down on Illegal Construction: Major Cities Face Scrutiny Amid Urban Planning Scandal
6 September 2025
-
Moroccan Police Bust International Phone Theft Ring: France-Morocco Sting Recovers Stolen Devices
6 September 2025
-
US Reaffirms Support for Moroccan Sovereignty in Western Sahara Dispute
6 September 2025
-
Severe Weather Alert: Moroccan Regions Brace for Intense Thunderstorms and Heavy Rainfall
6 September 2025